ATYPICAL TERATOID/RHABDOID TUMOR
Clinical trials for ATYPICAL TERATOID/RHABDOID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ATYPICAL TERATOID/RHABDOID TUMOR trials appear
Sign up with your email to follow new studies for ATYPICAL TERATOID/RHABDOID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tots with aggressive brain tumors
Disease control Recruiting nowThis study is testing a new, intensive chemotherapy plan for children under 6 with high-risk brain tumors. The main goal is to see if adding a specific spinal fluid chemotherapy and a long period of oral 'maintenance' drugs is a workable treatment plan. Researchers will also trac…
Matched conditions: ATYPICAL TERATOID/RHABDOID TUMOR
Phase: EARLY_PHASE1 • Sponsor: C17 Council • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for kids with aggressive, rare cancers
Disease control Recruiting nowThis study is testing whether three drugs given together can treat rare and aggressive childhood cancers caused by missing specific proteins. It will first find the safest dose and then see if the combination effectively controls these difficult tumors. The trial is for children …
Matched conditions: ATYPICAL TERATOID/RHABDOID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Susan Chi, MD • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for kids with tough cancers: Two-Drug attack enters trial
Disease control Recruiting nowThis study is testing a new oral drug, AMXT 1501, combined with an existing drug called DFMO, for children and young adults with aggressive cancers that have come back or didn't respond to standard treatments. The first part aims to find a safe dose, and the second part will comp…
Matched conditions: ATYPICAL TERATOID/RHABDOID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Doctors test Direct-to-Brain cell therapy for Kids' devastating tumors
Disease control Recruiting nowThis early-stage study is testing a new cell therapy for children and young adults with aggressive or returning brain tumors. Doctors collect a patient's own immune cells, engineer them in a lab to target a protein (B7H3) found on tumor cells, and then deliver these 'CAR T cells'…
Matched conditions: ATYPICAL TERATOID/RHABDOID TUMOR
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
New hope for kids with aggressive brain tumors: pioneering therapy delivered directly to the brain
Disease control Recruiting nowThis early-stage study is testing a new type of personalized immune therapy called B7-H3-CAR T cells for children and young adults (up to age 21) with brain tumors that have come back or haven't responded to standard treatments. The therapy involves collecting a patient's own imm…
Matched conditions: ATYPICAL TERATOID/RHABDOID TUMOR
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC